Immune-regulating bimetallic metal-organic framework nanoparticles designed for cancer immunotherapy
Immunogenic cell death (ICD) is a promising strategy in cancer immunotherapy to induce
high immunogenicity and activate the immune system. However, its efficacy is counteracted …
high immunogenicity and activate the immune system. However, its efficacy is counteracted …
Immune-regulating bimetallic metal-organic framework nanoparticles designed for cancer immunotherapy
Z Dai, Q Wang, J Tang, M Wu, H Li, Y Yang, X Zhen… - 2022 - digital.library.adelaide.edu.au
Immunogenic cell death (ICD) is a promising strategy in cancer immunotherapy to induce
high immunogenicity and activate the immune system. However, its efficacy is counteracted …
high immunogenicity and activate the immune system. However, its efficacy is counteracted …
Immune-regulating bimetallic metal-organic framework nanoparticles designed for cancer immunotherapy.
Z Dai, Q Wang, J Tang, M Wu, H Li, Y Yang, X Zhen… - Biomaterials, 2021 - europepmc.org
Immunogenic cell death (ICD) is a promising strategy in cancer immunotherapy to induce
high immunogenicity and activate the immune system. However, its efficacy is counteracted …
high immunogenicity and activate the immune system. However, its efficacy is counteracted …
Immune-regulating bimetallic metal-organic framework nanoparticles designed for cancer immunotherapy
Z Dai, Q Wang, J Tang, M Wu, H Li, Y Yang… - …, 2022 - research.monash.edu
Immunogenic cell death (ICD) is a promising strategy in cancer immunotherapy to induce
high immunogenicity and activate the immune system. However, its efficacy is counteracted …
high immunogenicity and activate the immune system. However, its efficacy is counteracted …
Immune-regulating bimetallic metal-organic framework nanoparticles designed for cancer immunotherapy
Z Dai, Q Wang, J Tang, M Wu, H Li, Y Yang… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Immunogenic cell death (ICD) is a promising strategy in cancer immunotherapy to induce
high immunogenicity and activate the immune system. However, its efficacy is counteracted …
high immunogenicity and activate the immune system. However, its efficacy is counteracted …
[引用][C] Immune-regulating bimetallic metal-organic framework nanoparticles designed for cancer immunotherapy
Z Dai, Q Wang, J Tang, M Wu, H Li, Y Yang… - …, 2021 - espace.library.uq.edu.au
Immunogenic cell death (ICD) is a promising strategy in cancer immunotherapy to induce
high immunogenicity and activate the immune system. However, its efficacy is counteracted …
high immunogenicity and activate the immune system. However, its efficacy is counteracted …